Oral Tablet Immunotherapy for Allergic Rhinitis: Advancing Management in the Pediatric Setting – American Academy of Pediatrics: New Jersey

Join Dr. Lawrence DuBuske for a Virtual CME Lecture on Allergic Rhinitis!

Date: Tuesday, September 26, 2023

Presentation: 12:30 PM – 2:00 PM EDT

Registration is required to receive the meeting link.

PROVIDER STATEMENT

Provided by Integrity Continuing Education, Inc.

DISCLOSURE OF COMMERCIAL SUPPORT

This activity is supported by an educational grant from ALK-Abello, Inc.

PROGRAM OVERVIEW

Allergic Rhinitis (AR) in children and adolescents is a commonly misunderstood, misdiagnosed, and mistreated condition. AR and AR with conjunctivitis (ARC) exerts significant effect on quality of life and has deleterious effects on sleep, academic performance, family functioning, and involvement in outdoor activities. Fortunately, there have been advances in the diagnosis and treatment of AR and ARC that support improved diagnosis and care of patients with inadequate relief from symptom-relieving therapies, including broadly available specific IgE tests, advances in understanding of immune mechanisms, and newer allergen immunotherapies including oral tablet immunotherapy.

This program will review these important updates to provide clinicians with the knowledge and skills to provide care of children and adolescents with AR and ARC that is aligned with the latest evidence and best-practices.

FACULTY

Lawrence M. DuBuske, MD
Physician
George Washington University Hospital
Clinical Professor of Medicine
The George Washington University School of Medicine and Health Sciences (2010-2021)
Washington, District of Columbia

TARGET AUDIENCE

This educational initiative has been designed for pediatricians and pediatric NPs and PAs in pediatric care settings.

LEARNING OBJECTIVES

Upon completion of this educational activity, participants should be able to:

  • Discuss the burden of symptoms of AR and ARC and the associated impacts on quality of life in children and adolescents
  • Implement strategies for the early diagnosis and optimal assessment of AR and ARC in the pediatric setting
  • Describe the role of allergy immunotherapy in the management of patients with AR and ARC
  • Utilize available therapies to achieve optimal management of pediatric patients with AR and ARC

DIRECTIONS TO LEARNER

There are no fees for participating and receiving CME credit for this activity. To receive credit, participants must:

  • Read the learning objectives and faculty disclosures
  • Complete the pretest
  • View the live broadcast
  • Complete the posttest evaluation form at the end of the program

Your certificate will be sent to you within four weeks of receipt of the completed evaluation.

MEDIA

Internet

ACCREDITATION STATEMENT

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Integrity Continuing Education, Inc. designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CONTACT INFORMATION

For information about ACCME accreditation of this activity, please contact Integrity Continuing Education, Inc. at (855) 835-4004 or cme@integrityce.com.

DISCLOSURE OF CONFLICTS OF INTEREST

Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any financial relationships with ineligible companies. All identified relevant financial relationships are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. All relevant financial relationships have been mitigated.

The following faculty/planners reported the financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity:

Lawrence M. DuBuske, MD
Board: Abionics, ALK-Abello, Allergy Therapeutics, AstraZeneca, GlaxoSmithKline, Regeneron, Sanofi
Speaker: ALK-Abello, AstraZeneca, GlaxoSmithKline, Novartis, Regeneron, Sanofi
Research: Abionics, AstraZeneca, Regeneron

The Integrity Continuing Education, Inc. planners and managers do not have any financial relationships or relationships to products or devices with ineligible companies.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. and Global Education Group do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

PRIVACY POLICY

When you participate in an online educational activity sponsored by Integrity Continuing Education, Inc., you will be asked for your name, degree(s), affiliation(s), street address, telephone number and…(continued)

MINIMUM SYSTEM REQUIREMENTS

Minimum Processor: Intel Pentium 4, 2.33 + GHz (or equivalent)
Operating Systems: Windows XP, Windows 2000, Windows Vista, Windows 7, Windows 10, and Mac OS
Plug-in: Adobe® Flash® Player 10
• Adobe® Flash® Player 10 plug-in should be downloaded
• Click on the “Agree and install now” button after unchecking the optional McAfee Security Scan Plus
For optimal performance, the use of Internet Explorer below 8 is not recommended

For a full listing of recommended operating systems, browsers, and system configurations, please click on the link below:
Click here for more information on minimum system requirements

DISCLAIMER

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Agenda

On the day of the program, you may access the event by going to the following link: https://integrityce.com/NJVirtual. Once you submit your answers to the pretest, you will be redirected to the zoom meeting.

There are no fees for participating and receiving CME credit for this activity. For your participation you will be able to receive a maximum of 1.5 AMA PRA Category 1 CME creditsTM. To do so, you must participate in the virtual livestream activity and complete the posttest and evaluation following the event. A statement of credit will be issued within 4 weeks of submission of a completed activity evaluation form.